Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $17.2 Million - $28.1 Million
-76,281 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $16.9 Million - $37 Million
76,281 New
76,281 $28.7 Million
Q1 2020

Apr 09, 2020

SELL
$17.78 - $31.58 $394,271 - $700,286
-22,175 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$13.93 - $21.28 $308,897 - $471,884
22,175 New
22,175 $434,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.